Personal information

Cancer, Sarcoma, VRK1
Spain

Activities

Employment (2)

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz: Madrid, Madrid, ES

2021-12-01 to present | Postdoctoral Researcher (Sara Borrell fellowship) (ATBSarc Group)
Employment
Source: Self-asserted source
David Moura

Instituto de Biomedicina de Sevilla: Sevilla, Andalucía, ES

2016-04-12 to 2021-11-30 | Postdoctoral Researcher (Advanced Therapies and Biomarkers in Oncology)
Employment
Source: Self-asserted source
David Moura

Education and qualifications (1)

Universidad de Salamanca: Salamanca, Castilla y León, ES

2011-09-01 to 2016-04-08 | PhD (IBSAL)
Education
Source: Self-asserted source
David Moura

Works (50 of 89)

Items per page:
Page 1 of 2

Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)

Journal of Clinical Oncology
2025-01-20 | Journal article
Contributors: Javier Martin-Broto; Roberto Diaz-Beveridge; David Moura; Rafael Ramos; Javier Martinez-Trufero; Irene Carrasco; Ana Sebio; Enrique González-Billalabeitia; Antonio Gutierrez; Javier Fernandez-Jara et al.
Source: check_circle
Crossref

HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Cellular and Molecular Life Sciences
2024-12 | Journal article
Contributors: David S. Moura; Jose L. Mondaza-Hernandez; Paloma Sanchez-Bustos; Maria Peña-Chilet; Juan A. Cordero-Varela; Maria Lopez-Alvarez; Jaime Carrillo-Garcia; Marta Martin-Ruiz; Pablo Romero-Gonzalez; Marta Renshaw-Calderon et al.
Source: check_circle
Crossref

Data from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

Clinical Cancer Research
2024-11-15 | Journal article
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Table S1 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Table S2 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Table S3 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Supplementary Table S4 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

2024-11-15 | Preprint
Contributors: David S. Moura; Jesus M. Lopez-Marti; Iva Benesova; Carlos de Andrea; Davide di Lernia; Serena Lacerenza; Jose L. Mondaza-Hernandez; Marta Martin-Ruiz; Marta Ramirez-Calvo; Giovanni Grignani et al.
Source: check_circle
Crossref

Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

Clinical Cancer Research
2024-06-03 | Journal article
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Data from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Data from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S1 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S1 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S2 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S2 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S3 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Figure S3 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S1 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S1 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S2 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S2 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S3 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S3 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S4 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S4 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S5 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S5 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S6 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S6 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S7 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Supplementary Table S7 from Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

2024-06-03 | Preprint
Contributors: Jiangang Liu; David S. Moura; Robin L. Jones; Amit Aggarwal; Philip J. Ebert; Andrew J. Wagner; Jennifer Wright; Javier Martin-Broto; William D. Tap
Source: check_circle
Crossref

Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature

Cancers
2023-10-28 | Journal article
Contributors: Carlos Torrado; Melisa Camaño; Nadia Hindi; Justo Ortega; Alberto R. Sevillano; Gema Civantos; David S. Moura; Alessandra Dimino; Javier Martín-Broto
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Reduction of Tumor Growth with RNA-Targeting Treatment of the NAB2–STAT6 Fusion Transcript in Solitary Fibrous Tumor Models

Cancers
2023-06-09 | Journal article
Contributors: Yi Li; John T. Nguyen; Manasvini Ammanamanchi; Zikun Zhou; Elijah F. Harbut; Jose L. Mondaza-Hernandez; Clark A. Meyer; David S. Moura; Javier Martin-Broto; Heather N. Hayenga et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Data from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Data from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Data from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S1 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S1 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S2 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S2 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S3 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S3 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S4 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref

Supplementary Table S4 from Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

2023-04-03 | Preprint
Contributors: Javier Martin-Broto; Maria Lopez-Alvarez; David S. Moura; Rafael Ramos; Paola Collini; Cleofe Romagosa; Silvia Bagué; Salvatore L. Renne; Marta Barisella; Valerie Velasco et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 2

Peer review (3 reviews for 2 publications/grants)

Review activity for Laboratory investigation. (2)
Review activity for Nature communications (1)